Related Experiment Videos
Vitamin D and cancer.
C S Spina1, V Tangpricha, M Uskokovic
1Vitamin D, Skin and Bone Research Laboratory, Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Anticancer Research
|August 5, 2006
Summary
Vitamin D deficiency increases colon tumor growth. Novel Gemini analogs of 1,25-dihydroxyvitamin D [1,25(OH)2D3] show significant potential for treating colon cancer by inhibiting tumor growth.
Area of Science:
- Oncology
- Endocrinology
- Nutritional Science
Background:
- Sunlight exposure correlates with reduced cancer rates.
- Vitamin D's role in cancer prevention is increasingly recognized.
- Activated vitamin D (1,25(OH)2D3) inhibits cellular proliferation.
Purpose of the Study:
- To investigate the impact of vitamin D deficiency on colon tumor growth.
- To evaluate novel Gemini analogs of 1,25(OH)2D3 for cancer therapeutic potential.
Main Methods:
- Vitamin D deficiency induced in mice to assess colon tumor growth.
- In vitro and in vivo evaluation of novel Gemini 1,25(OH)2D3-analogs.
- Comparison of Gemini analogs' efficacy against parent compounds in inhibiting tumor growth.
Main Results:
- Vitamin D deficiency in mice resulted in a 60% increase in colon tumor growth.
- Novel Gemini analogs demonstrated superior efficacy compared to parent compounds.
- Select Gemini analogs were over 100 times more effective in inhibiting mouse colon tumor growth.
Conclusions:
- Correcting vitamin D deficiency may lower colon cancer risk.
- Novel Gemini 1,25(OH)2D3-analogs show promise for human colon cancer therapy.